查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1652742

肝臟移植市場：2025 年至 2032 年全球產業分析、規模、佔有率、成長、趨勢與預測

Liver Transplantation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 217 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份有關全球肝臟移植市場的詳盡報告。該報告對市場促進因素、趨勢、機會和挑戰等關鍵市場動態進行了全面的分析，並對市場結構提供了深入的見解。

關鍵見解

  • 肝臟移植市場規模（2025年預測）：19.01億美元
  • 預計市場價值（2032F）：30.101億美元
  • 全球市場成長率（2025-2032 年複合年成長率）：6.8%

肝臟移植市場報告內容：

肝臟移植市場包括用於治療肝硬化、肝細胞癌和急性肝功能衰竭等嚴重肝病的肝臟移植的各種程序、技術和捐贈者來源。該市場包括屍體和活體肝臟移植技術，外科手術、免疫抑制劑和術後護理的進步正在推動其成長。肝病發生率的不斷上升以及器官捐贈接受度的不斷提高推動了市場擴張。

市場成長動力：

有幾個關鍵因素推動全球肝臟移植市場的發展。因飲酒、病毒性肝炎和非酒精性脂肪性肝病（NAFLD）導致的肝病發生率不斷上升，大大增加了肝臟移植的需求。此外，微創植入和機器人輔助手術等手術技術的進步提高了成功率和患者的治療效果。新型免疫抑制劑的開發也降低了器官排斥的風險，進一步推動了市場的成長。此外，政府推動器官捐贈和移植基礎設施發展的舉措和意識提升計劃預計將推動市場擴張。

市場限制：

儘管成長前景看好，但肝臟移植市場仍面臨若干挑戰。肝臟移植的費用高昂，包括術前、手術和術後費用，仍然是一個主要障礙，尤其是在開發中國家。捐贈器官的有限供應進一步限制了市場的成長，導致有需要的病人需要長時間等候，死亡率也上升。此外，感染疾病、器官排斥和免疫抑制治療的副作用等移植後併發症對移植的成功構成了挑戰。有關器官採購的嚴格監管要求和道德問題也影響了市場擴張。

市場機會：

器官保存和移植技術的進步為市場提供了巨大的機會。機器灌注技術的引入有望提高供肝的存活率和延長供肝的保存期，從而提高移植的成功率。 3D 列印肝組織和幹細胞療法等生物工程和再生醫學的日益普及為傳統移植提供了一個有希望的替代方案。此外，對移植中心的投資增加、醫療保健組織之間的合作以及促進活體捐贈計劃的舉措提供了新的成長途徑。新興經濟體擴大醫療保健覆蓋率和優惠的報銷政策也促進了市場的發展。

本報告探討的關鍵問題

  • 推動全球肝臟移植市場成長的關鍵因素有哪些？
  • 科技進步如何影響肝臟移植市場的競爭格局？
  • 肝臟移植患者和醫療保健提供者面臨的主要挑戰是什麼？
  • 誰是肝臟移植市場的關鍵參與者，他們採取什麼策略來保持競爭力？
  • 全球肝臟移植市場有哪些新興趨勢與前景？

目錄

第1章執行摘要

第2章 市場概況

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
    • 主要趨勢
  • 產品類型生命週期分析
  • 肝臟移植市場：價值鏈
    • 原物料供應商名單
    • 製造商列表
    • 經銷商名單
    • 應用程式列表
    • 盈利分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
    • 全球母市場概覽
  • 預測因子－相關性和影響力
  • 監管和技術格局

第 3 章 全球肝臟移植市場展望：歷史（2019-2023）與預測（2025-2032）

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模及與前一年同期比較率
    • 絕對商機
  • 市場規模（百萬美元）分析及預測
    • 2019 年至 2023 年歷史市場規模分析
    • 目前市場規模預測，2025-2032
  • 全球肝臟移植市場展望：產品類型
    • 簡介/主要發現
    • 2019 年至 2023 年歷史市場規模（百萬美元）和銷售（單位）分析（按產品類型）
    • 當前市場規模（百萬美元）和銷售（單位）預測，2025-2032 年，按產品類型分類
      • 器官保存解決方案
      • 免疫抑制劑
      • 其他
  • 市場吸引力分析：產品類型
  • 全球肝臟移植市場展望：治療類型
    • 簡介/主要發現
    • 2019 年至 2023 年按治療類型分類的歷史市場規模（百萬美元）和銷售量（單位）分析
    • 當前市場規模（百萬美元）和銷售（單位）預測，2025-2032 年，按治療類型分類
      • 肝臟移植手術
      • 術後抗排斥治療
      • Cyclosporine
      • Tacrolimus
      • Sirolimus潑尼松Azathioprine
      • Mycophenolate Mofetil
  • 市場吸引力分析：治療類型
  • 全球肝臟移植市場展望：最終用途
    • 簡介/主要發現
    • 2019 年至 2023 年歷史市場規模（百萬美元）和銷售（單位）分析，按最終用途
    • 當前市場規模（百萬美元）和 2025-2032 年銷售（單位）預測（按最終用途）
      • 醫院
      • 成人肝臟移植中心
      • 門診手術中心
  • 市場吸引力分析：最終用途

4. 全球肝臟移植市場展望-區域

  • 主要亮點
  • 2019 年至 2023 年按地區分類的歷史市場規模（百萬美元）和銷售量（單位）分析
  • 2025 年至 2032 年各地區目前市場規模（百萬美元）及銷售量（單位）預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和太平洋
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

第 5 章北美肝臟移植市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

6. 歐洲肝臟移植市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 7 章東亞肝臟移植市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

8. 南亞和大洋洲肝臟移植市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第 9 章拉丁美洲肝臟移植市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 10 章中東和非洲肝臟移植市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第11章 競爭格局

  • 2024 年市場佔有率分析
  • 市場結構
    • 市場競爭加劇圖
    • 競爭性免疫抑制劑
    • 表觀產品體積
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Allosource
    • Conatus Pharmaceuticals Inc.
    • Digna Biotech SL
    • Dompe Farmaceutici SpA
    • Isogenis, Inc.
    • RedHill Biopharma Ltd.
    • Thompson Surgical
    • Integra Life Sciences
    • Baxter International Inc.
    • XVIVO
    • VirTech Bio
    • Vital Therapies
    • HepaTx

第12章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP33816

Persistence Market Research has recently published an extensive report on the global Liver Transplantation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Liver Transplantation Market Size (2025E): USD 1901 Mn
  • Projected Market Value (2032F): USD 3010.1 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.8%

Liver Transplantation Market - Report Scope:

The Liver Transplantation Market encompasses a range of procedures, technologies, and donor sources for liver transplants, primarily used to treat severe liver diseases, including cirrhosis, hepatocellular carcinoma, and acute liver failure. The market involves both cadaveric and living donor transplantation techniques, with advancements in surgical procedures, immunosuppressive drugs, and post-operative care driving growth. The increasing prevalence of liver diseases, coupled with the growing acceptance of organ donation, is fueling market expansion.

Market Growth Drivers:

Several key factors are driving the global Liver Transplantation Market. The rising incidence of liver diseases due to alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) has significantly increased the demand for liver transplants. Moreover, advancements in surgical techniques, including minimally invasive transplantation and robotic-assisted surgeries, have improved success rates and patient outcomes. The development of new immunosuppressive drugs has also reduced the risk of organ rejection, further supporting market growth. Additionally, government initiatives and awareness programs promoting organ donation and transplantation infrastructure development are expected to boost market expansion.

Market Restraints:

Despite promising growth prospects, the Liver Transplantation Market faces several challenges. The high cost of liver transplantation, including pre-operative, surgical, and post-operative expenses, remains a significant barrier, particularly in developing countries. The limited availability of donor organs further restricts market growth, leading to long waiting lists and increased mortality rates among patients in need. Additionally, post-transplant complications such as infections, organ rejection, and side effects of immunosuppressive therapy pose challenges to successful transplant outcomes. Stringent regulatory requirements and ethical concerns regarding organ procurement also impact market expansion.

Market Opportunities:

The market presents significant opportunities driven by technological advancements in organ preservation and transplant techniques. The introduction of machine perfusion technology, which enhances the viability of donor livers and extends preservation time, is expected to improve transplant success rates. The increasing adoption of bioengineering and regenerative medicine, including 3D-printed liver tissues and stem cell therapy, offers promising alternatives to traditional transplantation. Furthermore, growing investments in transplant centers, collaborations between healthcare organizations, and initiatives promoting living donor programs provide new growth avenues. Expanding healthcare access in emerging economies and favorable reimbursement policies also contribute to market development.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Liver Transplantation Market globally?
  • How are technological advancements influencing the competitive landscape of the Liver Transplantation Market?
  • What are the major challenges faced by liver transplant patients and healthcare providers?
  • Who are the key players in the Liver Transplantation Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Liver Transplantation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Liver Transplantation Market, including healthcare institutions, pharmaceutical companies, and medical device manufacturers, focus on research and development to improve transplant success rates and patient outcomes. Companies invest in developing advanced organ preservation solutions, artificial liver support devices, and improved immunosuppressants to address transplant-related challenges. Collaborations between transplant centers and biotechnology firms are facilitating new treatment modalities, such as xenotransplantation and bioengineered livers. Additionally, initiatives aimed at increasing organ donation rates and improving accessibility to transplantation services are being implemented to drive market growth.

Key Companies Profiled:

  • Allosource
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech S.L.
  • Dompe Farmaceutici S.p.A.
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
  • Thompson Surgical
  • Integra Life Sciences
  • Baxter International Inc.
  • XVIVO
  • VirTech Bio

Liver Transplantation Market Research Segmentation

By Product Type:

  • Organ Preservation Solutions
  • Immunosuppressive Drugs
  • Others

By Treatment Type:

  • Liver Transplantation Surgery
  • Post-Surgery Anti-Rejection Treatment
  • Cyclosporine
  • Tacrolimus
  • Sirolimus Prednisone Azathioprine
  • Mycophenolate Mofetil

By End-use:

  • Hospitals
  • Adult Liver Transplantation Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Liver Transplantation Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Liver Transplantation Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Liver Transplantation Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
      • 3.3.3.1. Organ Preservation Solutions
      • 3.3.3.2. Immunosuppressive Drugs
      • 3.3.3.3. Others
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Liver Transplantation Market Outlook: Treatment Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
      • 3.5.3.1. Liver Transplantation Surgery
      • 3.5.3.2. Post-Surgery Anti-Rejection Treatment
      • 3.5.3.3. Cyclosporine
      • 3.5.3.4. Tacrolimus
      • 3.5.3.5. Sirolimus Prednisone Azathioprine
      • 3.5.3.6. Mycophenolate Mofetil
  • 3.6. Market Attractiveness Analysis: Treatment Type
  • 3.7. Global Liver Transplantation Market Outlook: End-use
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Adult liver transplantation centers
      • 3.7.3.3. Ambulatory surgical centers
  • 3.8. Market Attractiveness Analysis: End-use

4. Global Liver Transplantation Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By Treatment Type
    • 5.3.4. By End-use
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 5.5.1. Organ Preservation Solutions
    • 5.5.2. Immunosuppressive Drugs
    • 5.5.3. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 5.6.1. Liver Transplantation Surgery
    • 5.6.2. Post-Surgery Anti-Rejection Treatment
    • 5.6.3. Cyclosporine
    • 5.6.4. Tacrolimus
    • 5.6.5. Sirolimus Prednisone Azathioprine
    • 5.6.6. Mycophenolate Mofetil
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 5.7.1. Hospitals
    • 5.7.2. Adult liver transplantation centers
    • 5.7.3. Ambulatory surgical centers
  • 5.8. Market Attractiveness Analysis

6. Europe Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Treatment Type
    • 6.3.4. By End-use
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 6.5.1. Organ Preservation Solutions
    • 6.5.2. Immunosuppressive Drugs
    • 6.5.3. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 6.6.1. Liver Transplantation Surgery
    • 6.6.2. Post-Surgery Anti-Rejection Treatment
    • 6.6.3. Cyclosporine
    • 6.6.4. Tacrolimus
    • 6.6.5. Sirolimus Prednisone Azathioprine
    • 6.6.6. Mycophenolate Mofetil
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 6.7.1. Hospitals
    • 6.7.2. Adult liver transplantation centers
    • 6.7.3. Ambulatory surgical centers
  • 6.8. Market Attractiveness Analysis

7. East Asia Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Treatment Type
    • 7.3.4. By End-use
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 7.5.1. Organ Preservation Solutions
    • 7.5.2. Immunosuppressive Drugs
    • 7.5.3. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 7.6.1. Liver Transplantation Surgery
    • 7.6.2. Post-Surgery Anti-Rejection Treatment
    • 7.6.3. Cyclosporine
    • 7.6.4. Tacrolimus
    • 7.6.5. Sirolimus Prednisone Azathioprine
    • 7.6.6. Mycophenolate Mofetil
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 7.7.1. Hospitals
    • 7.7.2. Adult liver transplantation centers
    • 7.7.3. Ambulatory surgical centers
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Treatment Type
    • 8.3.4. By End-use
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 8.5.1. Organ Preservation Solutions
    • 8.5.2. Immunosuppressive Drugs
    • 8.5.3. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 8.6.1. Liver Transplantation Surgery
    • 8.6.2. Post-Surgery Anti-Rejection Treatment
    • 8.6.3. Cyclosporine
    • 8.6.4. Tacrolimus
    • 8.6.5. Sirolimus Prednisone Azathioprine
    • 8.6.6. Mycophenolate Mofetil
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 8.7.1. Hospitals
    • 8.7.2. Adult liver transplantation centers
    • 8.7.3. Ambulatory surgical centers
  • 8.8. Market Attractiveness Analysis

9. Latin America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Treatment Type
    • 9.3.4. By End-use
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 9.5.1. Organ Preservation Solutions
    • 9.5.2. Immunosuppressive Drugs
    • 9.5.3. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 9.6.1. Liver Transplantation Surgery
    • 9.6.2. Post-Surgery Anti-Rejection Treatment
    • 9.6.3. Cyclosporine
    • 9.6.4. Tacrolimus
    • 9.6.5. Sirolimus Prednisone Azathioprine
    • 9.6.6. Mycophenolate Mofetil
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 9.7.1. Hospitals
    • 9.7.2. Adult liver transplantation centers
    • 9.7.3. Ambulatory surgical centers
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Treatment Type
    • 10.3.4. By End-use
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 10.5.1. Organ Preservation Solutions
    • 10.5.2. Immunosuppressive Drugs
    • 10.5.3. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 10.6.1. Liver Transplantation Surgery
    • 10.6.2. Post-Surgery Anti-Rejection Treatment
    • 10.6.3. Cyclosporine
    • 10.6.4. Tacrolimus
    • 10.6.5. Sirolimus Prednisone Azathioprine
    • 10.6.6. Mycophenolate Mofetil
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 10.7.1. Hospitals
    • 10.7.2. Adult liver transplantation centers
    • 10.7.3. Ambulatory surgical centers
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Immunosuppressive Drugs
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Allosource
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Conatus Pharmaceuticals Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Digna Biotech S.L.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Dompe Farmaceutici S.p.A.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Isogenis, Inc.
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. RedHill Biopharma Ltd.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Thompson Surgical
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Integra Life Sciences
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Baxter International Inc.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. XVIVO
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. VirTech Bio
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Vital Therapies
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. HepaTx
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations